FDA OKs Vivus Weight Drug Qsymia After Nod To Rival Arena
The U.S. Food and Drug Administration on Tuesday approved Mountain View, Calif.-based drugmaker Vivus Inc.'s weight-loss drug Qsymia, weeks after approving rival Arena Pharmaceuticals Inc.'s weight-loss treatment Belviq....To view the full article, register now.
Already a subscriber? Click here to view full article